Sinco Pharmaceuticals Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
52.00
107.00
110.00
115.00
201.00
152.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
109.00
-352.00
270.00
-6.00
169.00
-5.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
188.00
-269.00
375.00
67.00
342.00
147.00
Cash Flow from Investing Activities
-30.00
-57.00
-70.00
-140.00
-28.00
-53.00
Cash Flow from Financing Activities
-219.00
185.00
-194.00
123.00
-90.00
-183.00
Net Cash Inflow / Outflow
-64.00
-140.00
120.00
65.00
219.00
-91.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-3.00
1.00
9.00
14.00
-4.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sinco Pharmaceuticals Holdings Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
52.3380133477032
53.2696189232829
-1.00
-1.75%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
109.158361786603
24.2065616345876
85.00
350.95%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
188.695136748659
87.2206230438369
101.00
116.34%
Cash Flow from Investing Activities
-30.157341369684
-31.1334124034098
1.00
3.14%
Cash Flow from Financing Activities
-219.5986301974
-19.6049289726004
-200.00
-1020.12%
Net Cash Inflow / Outflow
-64.1181062004924
31.5715598451828
-95.00
-303.09%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-3.05727138206708
-4.91072182264394
1.00
37.74%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 169.91% vs -171.91% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
188.70
-269.93
169.91%






